Cargando…
P963: EVOLUTION OF TREATMENT PATTERNS AND OVERALL SURVIVAL IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING A SECOND LINE OF THERAPY BETWEEN 2012 AND 2020: ANALYSIS OF THE PREAMBLE COHORT
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430142/ http://dx.doi.org/10.1097/01.HS9.0000846720.60768.ed |
| _version_ | 1784779671451205632 |
|---|---|
| author | Kuter, D. Goldschmidt, H. Cella, D. Petrucci, M. T. Moreau, P. Durie, B. Juarez-Garcia, A. Trong, L. Gu, J. Hernandez Rivera, G. Dhanasiri, S. Marshall, T. Wang, J. Lacoin, L. Ramasamy, K. Vij, R. |
| author_facet | Kuter, D. Goldschmidt, H. Cella, D. Petrucci, M. T. Moreau, P. Durie, B. Juarez-Garcia, A. Trong, L. Gu, J. Hernandez Rivera, G. Dhanasiri, S. Marshall, T. Wang, J. Lacoin, L. Ramasamy, K. Vij, R. |
| author_sort | Kuter, D. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430142 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94301422022-08-31 P963: EVOLUTION OF TREATMENT PATTERNS AND OVERALL SURVIVAL IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING A SECOND LINE OF THERAPY BETWEEN 2012 AND 2020: ANALYSIS OF THE PREAMBLE COHORT Kuter, D. Goldschmidt, H. Cella, D. Petrucci, M. T. Moreau, P. Durie, B. Juarez-Garcia, A. Trong, L. Gu, J. Hernandez Rivera, G. Dhanasiri, S. Marshall, T. Wang, J. Lacoin, L. Ramasamy, K. Vij, R. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430142/ http://dx.doi.org/10.1097/01.HS9.0000846720.60768.ed Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Kuter, D. Goldschmidt, H. Cella, D. Petrucci, M. T. Moreau, P. Durie, B. Juarez-Garcia, A. Trong, L. Gu, J. Hernandez Rivera, G. Dhanasiri, S. Marshall, T. Wang, J. Lacoin, L. Ramasamy, K. Vij, R. P963: EVOLUTION OF TREATMENT PATTERNS AND OVERALL SURVIVAL IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING A SECOND LINE OF THERAPY BETWEEN 2012 AND 2020: ANALYSIS OF THE PREAMBLE COHORT |
| title | P963: EVOLUTION OF TREATMENT PATTERNS AND OVERALL SURVIVAL IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING A SECOND LINE OF THERAPY BETWEEN 2012 AND 2020: ANALYSIS OF THE PREAMBLE COHORT |
| title_full | P963: EVOLUTION OF TREATMENT PATTERNS AND OVERALL SURVIVAL IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING A SECOND LINE OF THERAPY BETWEEN 2012 AND 2020: ANALYSIS OF THE PREAMBLE COHORT |
| title_fullStr | P963: EVOLUTION OF TREATMENT PATTERNS AND OVERALL SURVIVAL IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING A SECOND LINE OF THERAPY BETWEEN 2012 AND 2020: ANALYSIS OF THE PREAMBLE COHORT |
| title_full_unstemmed | P963: EVOLUTION OF TREATMENT PATTERNS AND OVERALL SURVIVAL IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING A SECOND LINE OF THERAPY BETWEEN 2012 AND 2020: ANALYSIS OF THE PREAMBLE COHORT |
| title_short | P963: EVOLUTION OF TREATMENT PATTERNS AND OVERALL SURVIVAL IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING A SECOND LINE OF THERAPY BETWEEN 2012 AND 2020: ANALYSIS OF THE PREAMBLE COHORT |
| title_sort | p963: evolution of treatment patterns and overall survival in patients with relapsed/refractory multiple myeloma receiving a second line of therapy between 2012 and 2020: analysis of the preamble cohort |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430142/ http://dx.doi.org/10.1097/01.HS9.0000846720.60768.ed |
| work_keys_str_mv | AT kuterd p963evolutionoftreatmentpatternsandoverallsurvivalinpatientswithrelapsedrefractorymultiplemyelomareceivingasecondlineoftherapybetween2012and2020analysisofthepreamblecohort AT goldschmidth p963evolutionoftreatmentpatternsandoverallsurvivalinpatientswithrelapsedrefractorymultiplemyelomareceivingasecondlineoftherapybetween2012and2020analysisofthepreamblecohort AT cellad p963evolutionoftreatmentpatternsandoverallsurvivalinpatientswithrelapsedrefractorymultiplemyelomareceivingasecondlineoftherapybetween2012and2020analysisofthepreamblecohort AT petruccimt p963evolutionoftreatmentpatternsandoverallsurvivalinpatientswithrelapsedrefractorymultiplemyelomareceivingasecondlineoftherapybetween2012and2020analysisofthepreamblecohort AT moreaup p963evolutionoftreatmentpatternsandoverallsurvivalinpatientswithrelapsedrefractorymultiplemyelomareceivingasecondlineoftherapybetween2012and2020analysisofthepreamblecohort AT durieb p963evolutionoftreatmentpatternsandoverallsurvivalinpatientswithrelapsedrefractorymultiplemyelomareceivingasecondlineoftherapybetween2012and2020analysisofthepreamblecohort AT juarezgarciaa p963evolutionoftreatmentpatternsandoverallsurvivalinpatientswithrelapsedrefractorymultiplemyelomareceivingasecondlineoftherapybetween2012and2020analysisofthepreamblecohort AT trongl p963evolutionoftreatmentpatternsandoverallsurvivalinpatientswithrelapsedrefractorymultiplemyelomareceivingasecondlineoftherapybetween2012and2020analysisofthepreamblecohort AT guj p963evolutionoftreatmentpatternsandoverallsurvivalinpatientswithrelapsedrefractorymultiplemyelomareceivingasecondlineoftherapybetween2012and2020analysisofthepreamblecohort AT hernandezriverag p963evolutionoftreatmentpatternsandoverallsurvivalinpatientswithrelapsedrefractorymultiplemyelomareceivingasecondlineoftherapybetween2012and2020analysisofthepreamblecohort AT dhanasiris p963evolutionoftreatmentpatternsandoverallsurvivalinpatientswithrelapsedrefractorymultiplemyelomareceivingasecondlineoftherapybetween2012and2020analysisofthepreamblecohort AT marshallt p963evolutionoftreatmentpatternsandoverallsurvivalinpatientswithrelapsedrefractorymultiplemyelomareceivingasecondlineoftherapybetween2012and2020analysisofthepreamblecohort AT wangj p963evolutionoftreatmentpatternsandoverallsurvivalinpatientswithrelapsedrefractorymultiplemyelomareceivingasecondlineoftherapybetween2012and2020analysisofthepreamblecohort AT lacoinl p963evolutionoftreatmentpatternsandoverallsurvivalinpatientswithrelapsedrefractorymultiplemyelomareceivingasecondlineoftherapybetween2012and2020analysisofthepreamblecohort AT ramasamyk p963evolutionoftreatmentpatternsandoverallsurvivalinpatientswithrelapsedrefractorymultiplemyelomareceivingasecondlineoftherapybetween2012and2020analysisofthepreamblecohort AT vijr p963evolutionoftreatmentpatternsandoverallsurvivalinpatientswithrelapsedrefractorymultiplemyelomareceivingasecondlineoftherapybetween2012and2020analysisofthepreamblecohort |